Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
Advances in Therapy|June 5, 2017
Monitoring for and Characterizing Crizotinib Progression: A Chart Review of ALK-Positive Non-Small Cell Lung Cancer PatientsEdmond Bendaly, Anand A Dalal, Kenneth Culver, et al.Advances in Therapy|April 14, 2017
Treatment Patterns and Early Outcomes of ALK-Positive Non-Small Cell Lung Cancer Patients Receiving Ceritinib: A Chart Review StudyEdmond Bendaly, Anand A Dalal, Kenneth Culver, et al.Journal of Medical Economics|November 26, 2014
Lifetime cost of everolimus vs axitinib in patients with advanced renal cell carcinoma who failed prior sunitinib therapy in the USAllison Perrin, Steven Sherman, Sumanta Pal, et al.Cancer Epidemiology|April 28, 2015
ALK rearrangement testing and treatment patterns for patients with ALK-positive non-small cell lung cancerAnnie Guérin, Medha Sasane, Jie Zhang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2008
Histone deacetylase inhibitor panobinostat induces clinical responses with associated alterations in gene expression profiles in cutaneous T-cell lymphomaLeigh Ellis, Yan Pan, Gordon K Smyth, et al.Pageof 1